David J. Arthur, Chief Executive Officer at Salarius Pharmaceuticals, Inc. (SLRX), bought 2,175 shares at $1.15 ($3K) on 2020-02-11, disclosed to the SEC on 2020-02-12.
Open-market purchase of $3k SLRX by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SLRX | BUY | 2021-08-17 | $4K | — | Filing → |
| SLRX | BUY | 2020-08-20 | $1K | — | Filing → |